Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast CancerAdam Kraya, Katherine L. Nathanson, John Pluta et al.|Clinical Cancer Research|2019Cited by 103
Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific driversJennifer Shah, Katherine L. Nathanson, Dana Pueschl et al.|Nature Communications|2022Cited by 27